Sumitomo Pharma Co., Ltd.
SMDPY
Get informed when a big investor buys or sells
+ FollowMarket Cap$713.94B
Close$
Share Statistics
| Market cap | $713.94 Billion |
|---|---|
| Enterprise Value | $797.95 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $286.01 |
| Beta | 0.46 |
| Outstanding Shares | 435,626,000 |
Return
| Return on Equity | 27.98% |
|---|---|
| Return on Assets | 13.53% |
| Return on Invested Capital | 18.72% |
Valuation & Multiples
| P/E Ratio | 5.69 |
|---|---|
| PEG | 11.01 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 1.66 |
| Enterprise Value to EBIT | 7.31 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | 0.2 |
| Debt to Equity | 0.39 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Sumitomo Pharma Co., Ltd.
3,123 employees
CEO: Toru Kimura Sumitomo Pharma Co., Ltd. is a global company involved in the creation, production, and sale of a variety of products, including human pharmaceuticals, food ingredients and additives, and veterinary medicines. Its operations span across ...